Investigating how a specific protein affects the replication of the influenza virus
Role of RNA helicase DDX1 in influenza A virus replication
This study is looking at a protein called DDX1 to see how it helps the flu virus multiply, with the hope of finding new medicines that can stop the flu from making people sick.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arkansas at Fayetteville NIH-funded |
| Lab location | 1 site (Fayetteville, United States) |
| Project ID | NIH-10439323 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a protein called DDX1 in the replication process of the influenza A virus. By studying how this protein interacts with the virus and the host's cells, researchers aim to identify new antiviral drugs that can prevent the virus from spreading and causing illness. The project employs advanced techniques to analyze these interactions and determine how they can be targeted for therapeutic purposes. Ultimately, the goal is to develop effective treatments that can combat influenza infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at high risk for influenza infections, such as those with compromised immune systems or chronic respiratory conditions.
Not a fit: Patients who are not affected by influenza or who have already been vaccinated may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral medications that effectively treat or prevent influenza infections.
How similar studies have performed: Previous research has shown success in targeting host proteins to develop antiviral therapies, indicating that this approach has potential.
Where this research is happening
Fayetteville, United States
- University of Arkansas at Fayetteville — Fayetteville, United States (Active)
Researchers
- Principal investigator: Du, Yuchun — University of Arkansas at Fayetteville
- Study coordinator: Du, Yuchun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.